Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue Compression

June 20, 2013 updated by: CIBA VISION
The purpose of this study was to compare the fit and comfort of two types of contact lenses.

Study Overview

Detailed Description

The relationship between ocular comfort and the Optical Coherence Tomography (OCT) measurements of post lens clearance and ocular tissue compression was studied.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Miami, Florida, United States, 33136
        • McKnight Building, Bascom Palmer Eye Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Be of legal age of consent and sign Informed Consent document.
  • Normal binocularity.
  • Be able to wear soft contact lenses.
  • Willing to comply with the wear and study visit schedule.
  • Spherical contact lens prescription within 0.50 diopter of the available lens powers.
  • Spectacle cylinder less than or equal to 1.50 diopter.
  • Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

  • Eye injury or surgery within twelve weeks of enrollment.
  • Pre-existing ocular irritation that would preclude contact lens fitting.
  • Currently enrolled in any clinical trial.
  • Evidence of systemic or ocular abnormality, infection, or disease likely to affect successful wear of contact lenses or use of accessory solutions as determined by the investigator.
  • Other protocol-defined exclusion criteria may apply.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Lotrafilcon A test/lotrafilcon A control
Lotrafilcon A test contact lens worn first, with lotrafilcon A control contact lens worn second. Each product worn bilaterally for two days as follows: 20 minutes on Day 1 and 10 hours on Day 2.
Silicone hydrogel single vision, soft contact lens with alternate parameters
Silicone hydrogel single vision, soft contact lens
Other Names:
  • Night&Day
Investigational, nonsignificant risk device for measuring post lens clearance and ocular tissue compression during contact lens wear
Other: Lotrafilcon A control/lotrafilcon A test
Lotrafilcon A control contact lens worn first, with lotrafilcon A test contact lens worn second. Each product worn bilaterally for two days as follows: 20 minutes on Day 1 and 10 hours on Day 2.
Silicone hydrogel single vision, soft contact lens with alternate parameters
Silicone hydrogel single vision, soft contact lens
Other Names:
  • Night&Day
Investigational, nonsignificant risk device for measuring post lens clearance and ocular tissue compression during contact lens wear

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Final Comfort
Time Frame: Day 2, Hour 10
Comfort was assessed by the participant on a Visual Analog Scale of 0 to 100, where 0=Extremely Uncomfortable ("My eyes are in pain. I cannot tolerate my lenses") and 100=Extremely Comfortable ("My eyes feel GREAT, better than normal. I cannot feel my lenses").
Day 2, Hour 10

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Jianhua Wang, MD, PhD, Bascom Palmer Eye Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2011

Primary Completion (Actual)

December 1, 2011

Study Completion (Actual)

December 1, 2011

Study Registration Dates

First Submitted

August 25, 2011

First Submitted That Met QC Criteria

August 25, 2011

First Posted (Estimate)

August 26, 2011

Study Record Updates

Last Update Posted (Estimate)

June 28, 2013

Last Update Submitted That Met QC Criteria

June 20, 2013

Last Verified

November 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • P-367-C-800

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ocular Comfort

Clinical Trials on Lotrafilcon A test contact lens

Subscribe